Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01311128 · ClinicalTrials.gov registry record

Determination of the Accuracy of a Non-Invasive Continuous Blood Pressure Device

A clinical trial, sponsored by Oregon Health and Science University.

Terminated
Registry status
31
Enrollment target

NCT01311128 is a clinical trial that was terminated before completion, run by Oregon Health and Science University. The registered enrollment target is 31 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01311128 was terminated before completion, sponsored by Oregon Health and Science University.

TERMINATED
Registry status
31 participants
Enrollment target

Study Summary

This protocol will test a new non-invasive device, the T-line, in continuously determining heart rate and blood pressure in operative and critically ill patients. The accuracy of the device will be compared to the standard radial artery catheter, as well as to the non-invasive blood pressure cuff. The T-line will also be compared to the right heart catheter determining cardiac output in at least 20 patients. Hypothesis: the T-line device will determine blood pressure and heart rate as accurately as a standard radial arterial catheter and a blood pressure cuff in perioperative patients.

Interventions

  • DEVICE T-line hemodynamic monitoring device (placement and use)

Trial Details

FieldValue
Enrollment Target 31 participants
Start Date 2011-02-16
Est. Completion 2014-12-30

What the Registry Record Tells You About NCT01311128

The ClinicalTrials.gov registry entry for NCT01311128 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which T-line hemodynamic monitoring device (placement and use) is the first listed.

NCT01311128 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01311128 about?

NCT01311128 is a clinical study titled "Determination of the Accuracy of a Non-Invasive Continuous Blood Pressure Device". This protocol will test a new non-invasive device, the T-line, in continuously determining heart rate and blood pressure in operative and critically ill patients. The accuracy of the device will be compared to the standard radial artery catheter, as well as to the non-invasive blood pressure cuff. T...

What is the current status of trial NCT01311128?

This trial is currently terminated. The enrollment target is 31 participants. The study started on 2011-02-16. Estimated completion is 2014-12-30.

What interventions are being tested in trial NCT01311128?

The interventions under investigation include: T-line hemodynamic monitoring device (placement and use) (DEVICE).

Who is sponsoring clinical trial NCT01311128?

This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.